← Back to headlines
Vir Biotechnology Details Astellas Collaboration and Cash Runway
Vir Biotechnology has provided details on its $1.7 billion collaboration with Astellas and anticipates a cash runway extending into the second quarter of 2028, driven by the advancement of VIR-5500.
24 Feb, 07:05 — 24 Feb, 07:05
ℹOnly 1 source covers this story
